Olympus today announced it received FDA clearance for its new Evis X1 endoscopy system and two compatible gastrointestinal endoscopes. The FDA clearance covers Olympus’ GIF-1100 gastrointestinal videoscope indicated for use in the upper digestive tract, and the CF-HQ1100DL/I colonovideoscope indicated for use in the lower digestive tract. Olympus’s GI endoscopy systems are used by physicians […]
Olympus
Olympus launches EndoClot products for gastrointestinal procedures
Olympus announced the launch of its EndoClot offerings for use in gastrointestinal (GI) procedures in the Europe, Middle East and Africa (EMEA) region. The EndoClot portfolio supports hemostasis and lifting in endoscopic submucosal dissection or resection in GI procedures. Olympus launched the EndoClot adhesive, the EndoClot polysaccharide hemostatic spray and the EndoClot submucosal injection solution. […]
22 MedTech Innovator all-stars will pitch at DeviceTalks Boston
Nearly two dozen MedTech Innovator portfolio startups will pitch their technology to medtech industry innovators, executives and engineers at DeviceTalks Boston on May 10-11. The MedTech Innovator accelerator program picked the 22 all-stars from hundreds of applicants. The all-stars who will be featured over the two-day event at the Boston Convention and Exhibition Center are: […]
FDA sends warning letter to Olympus over endoscope manufacturing
The FDA issued Olympus a warning letter regarding adultered devices following an inspection of the company’s Tokyo facility. This marks the latest warning letter sent by the FDA to Olympus. The company received two separate letters at the end of last year. According to the letter, the agency conducted an inspection of the Tokyo facility […]
Olympus acquires GI stent maker Taewoong Medical for $370M
Olympus announced that it agreed to acquire Korea-based Taewoong Medical, a maker of medical devices, including stents, for $370 million. Taewoong Medical manufactures devices including gastrointestinal (GI) metallic stents. Olympus intends to use the acquisition to strengthen its GI endotherapy portfolio capabilities. According to a news release, Olympus plans to pay approximately $370 million in […]
Olympus to acquire cloud-AI endoscopy startup Odin Vision
Olympus announced today that it agreed to acquire cloud-based AI endoscopy technology developer Odin Vision. The agreement totals up to $79 million in upfront and milestone-based payments. London-based Odin Vision develops a portfolio of commercially available computer-aided detection/diagnostic (CAD) solutions. It also holds an innovation pipeline of cloud-enabled applciations. Clinicians and AI experts at the […]
Olympus launches power morcellator with FDA-advised changes
Olympus today announced the U.S. market launch of its Moresolution power morcellator, saying it supports the safe use of the gynecologic devices under FDA guidance. In 2020, the FDA issued final guidance on power morcellators after the devices faced questions about potentially spreading cancer. The agency recommended limiting laparoscopic power morcellation (LPM) to use with […]
Olympus applauds CMS move to expand access to colonoscopies
Olympus says CMS recently took a significant step forward to boost colorectal cancer care in the U.S. CMS, on Nov. 1, announced that it will eliminate Medicare cost-sharing for a follow-up colonoscopy after an at-home stool test returns a positive result. Defining such colonoscopies as preventative services means that Medicare beneficiaries will no longer have […]
Olympus’ Evident opens new Asia-Pacific HQ
Olympus‘ Evident announced that it opened its new Asia-Pacific headquarters in Singapore as it looks to expand in the APAC region. In April, Olympus completed the separation of its Scientific Solutions Division into a wholly-owned subsidiary called Evident. The move aimed to provide more room to focus on the continued growth of the company’s Medical […]
Olympus announces CEO succession plan
Olympus announced today that it tentatively appointed Stefan Kaufmann as director, representative executive officer, president and CEO. The company plans to appoint Kaufmann, the current director, executive officer and chief administrative offer, effective April 1, 2023. Yasuo Takeuchi currently serves in the roles to which Olympus appointed Kaufmann. He moves to the position of director, […]
Olympus launches new endoscopic ultrasound processor
Olympus announced today that it launched its new EU-ME3 endoscopic ultrasound processor platform. Tokyo-based Olympus says the EU-ME3 addresses needs of healthcare professionals for high-quality images during endoscopic ultrasounds. The company plans to launch the system in Europe, the Middle East, Africa, parts of Asia and Oceana during this fiscal year. Olympus’ technology assists in […]
